GeneThera Company Executives
| GTHR Stock | USD 0.0001 0.00 0.00% |
GeneThera employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Discussion of GeneThera's management performance can provide insight into the enterprise performance.
| Antonio MD Insider Chairman, Founder |
| Tannya Irizarry CFO Chief Admin. Officer, Interim CFO, Interim Principal Accounting Officer and Secretary |
GeneThera |
GeneThera Management Team Effectiveness
The company has return on total asset (ROA) of (95.3798) % which means that it has lost $95.3798 on every $100 spent on assets. This is way below average. GeneThera's management efficiency ratios could be used to measure how well GeneThera manages its routine affairs as well as how well it operates its assets and liabilities.GeneThera Workforce Comparison
GeneThera is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 1,153. GeneThera adds roughly 2.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
GeneThera Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. GeneThera Price Series Summation is a cross summation of GeneThera price series and its benchmark/peer.
GeneThera Notable Stakeholders
A GeneThera stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as GeneThera often face trade-offs trying to please all of them. GeneThera's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting GeneThera's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Tannya Irizarry | Chief Admin. Officer, Interim CFO, Interim Principal Accounting Officer and Secretary | Profile | |
| Antonio MD | Chairman, Founder | Profile |
About GeneThera Management Performance
The success or failure of an entity such as GeneThera often depends on how effective the management is. GeneThera management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of GeneThera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the GeneThera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. The companys Molecular RoboticAI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. Genethera operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
GeneThera Workforce Analysis
Traditionally, organizations such as GeneThera use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare GeneThera within its industry.GeneThera Manpower Efficiency
Return on GeneThera Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 505.7K | |
| Net Loss Per Executive | 505.7K |
Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.